查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
傷口皮膚替代市場 - 全球和區域分析：區域/國家分析、競爭格局、分析和預測（2023-2030）
市場調查報告書
商品編碼
1488258

傷口皮膚替代市場 - 全球和區域分析：區域/國家分析、競爭格局、分析和預測（2023-2030）

Wound Skin Substitutes Market - A Global and Regional Analysis: Focus on Region, Country-Level Analysis, and Competitive Landscape - Analysis and Forecast, 2023-2030
出版日期: | 出版商: BIS Research | 英文 41 Pages | 商品交期: 1-5個工作天內

價格

全球傷口皮膚替代市場規模將從2022年的11.81億美元成長到2030年的20.626億美元，在2023年至2030年的預測期內以7.35%的複合年成長率穩步成長。

糖尿病足潰瘍、壓瘡和腿部靜脈潰瘍等慢性傷口的增加急劇增加了對創新、有效的創傷治療解決方案的需求。

主要市場統計數據
預測期 2023-2030
2023年評估 12.555 億美元
2030年預測 20.626 億美元
複合年成長率 7.35%

生物材料的技術進步和更有效的皮膚替代產品的開發進一步推動了這一成長。此外，更容易患慢性病的老年人口的增加以及世界醫療基礎設施功能的不斷擴大也對市場的擴張做出了重大貢獻。進一步支持這一成長的是對改善患者治療結果和降低與慢性傷口相關的整體醫療成本的日益關注。

北美地區在全球市場中佔據主導地位，2022年佔有率將達到78.12%。這一巨大比例是由於多種因素造成的，包括人口老化、與糖尿病高度相關的肥胖症的迅速增加以及放射治療的後期影響。這些因素進一步推動患者採用傷口皮膚替代，帶來收益成長。由於慢性傷口發生率急劇上升、技術進步導致創新產品開發以及醫療保健成本上升，預計亞太、歐洲和拉丁美洲地區也將強勁成長。

參與企業：

  • Coloplast
  • Smith & Nephew
  • MTF Biologics
  • MiMedx Group, Inc
  • AlloSource
  • Organogenesis Inc.
  • RTI Surgical
  • LifeNet Health
  • Molecular Biologicals, Inc

本報告調查了全球傷口皮膚替代市場，並總結了市場概況、市場規模趨勢和預測、按地區/主要國家進行的詳細分析、競爭格局和主要企業簡介。

目錄

執行摘要

第1章 市場

第2章 區域

  • 區域概況
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 土耳其
    • 荷蘭
    • 俄羅斯
    • 瑞士
    • 波蘭
    • 奧地利
    • 捷克共和國
    • 瑞典
    • 羅馬尼亞
    • 愛爾蘭
    • 比利時
    • 希臘
    • 葡萄牙
    • 挪威
    • 斯洛伐克
    • 丹麥
    • 烏克蘭
    • 芬蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
    • 馬來西亞
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 智利
  • 其他地區

第3章市場：競爭基準化分析

  • 主要策略/發展
  • 主要企業生態系統

第4章調查方法

Product Code: BHM2078SA

Introduction of Wound Skin Substitutes

The global wound skin substitutes market, valued at $1,181.0 million in 2022, is on a robust growth trajectory and is anticipated to reach $2,062.6 million by 2030. This market is expected to expand at a compound annual growth rate (CAGR) of 7.35% between 2023 and 2030. Driven by the increasing prevalence of chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, the market is witnessing a surge in demand for innovative and effective wound healing solutions.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2023 - 2030
2023 Evaluation$1,255.5 Million
2030 Forecast$2,062.6 Million
CAGR7.35%

Technological advancements in biomaterials and the development of more efficient skin substitute products are further fueling this growth. Moreover, the rising geriatric population, which is more prone to chronic conditions, and the expanding capabilities of healthcare infrastructures globally are significant contributors to the market's expansion. This growth has also been supported by a growing focus on improving patient outcomes and reducing the overall healthcare costs associated with chronic wounds.

Regional Segmentation:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Russian Federation
    • Turkey
    • Poland
    • Belgium
    • Sweden
    • Ireland
    • Norway
    • Austria
    • Denmark
    • Finland
    • Portugal
    • Czech Republic
    • Romania
    • Greece
    • Slovakia
    • Ukraine
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Malaysia
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Colombia
    • Argentina
    • Chile
  • Rest-of-the-World

The global wound skin substitutes market has been dominated by North America, which held a 78.12% share in 2022. This significant share can be attributed to several factors, including an aging population, the steep rise in the prevalence of obesity that is heavily correlated to diabetes, and the late effects of radiation therapies. These factors have further boosted the adoption of wound skin substitutes among patients, thereby boosting revenue growth. Asia-Pacific, Europe, and Latin America regions are expected to witness significant growth in the wound skin substitutes market due to a surge in the incidence rate of chronic wounds, technological advancements leading to the development of innovative products, and increasing healthcare expenditure.

Recent Developments in the Wound Skin Substitutes Market

  • In July 2023, Coloplast announced an agreement to acquire Kerecis for up to $1.3 billion. Kerecis has pioneered patented technology for treating wounds and burns by utilizing unaltered fish skin.
  • In April 2023, Coloplast (Kerecis) announced MariGen Shield, which integrates the company's proven fish-skin graft with a silicone contact layer for treating chronic and complex wounds.
  • In January 2023, Coloplast (Kerecis) announced the release of two new products for the burn market, GraftGuide Mano and GraftGuide Micro. This latest innovation is a specialized fish skin product tailored for treating burns specifically on the hand.
  • In January 2022, Researchers from the University of Birmingham and the University of Huddersfield, UK, developed a new 3D bioprinting technique that could be used to treat chronic wounds.
  • In October 2021, Coloplast (Kerecis) received authorization from the FDA to market Kerecis Omega3 SurgiBind. This implant is a fish-skin graft that can be implanted for plastic and reconstructive surgical procedures.

How can this report add value to an organization?

Product/Innovation Strategy: By understanding specific regional needs and preferences highlighted in the report, a company can tailor its product development to address local market demands effectively. This might include innovation in skin substitute materials that cater to prevalent wound types in a particular region.

Growth/Marketing Strategy: With detailed regional data, companies can craft precise marketing strategies that resonate with local healthcare providers and patients. This includes choosing the right channels and messages that appeal to the specific demographic and economic conditions of the region.

Competitive Strategy: The report provides an analysis of key competitors in the region, allowing companies to benchmark their products and strategies. Knowing the competitive landscape helps in positioning their offerings more effectively to capture market share.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the market size is 2022. A historical year analysis has been done for the period FY2019-FY2021. The market size has been estimated for FY2022 and projected for the period FY2023-FY2030.
  • The scope of this report has been carefully derived based on interactions with experts in different companies worldwide. This report provides a market study of upstream and downstream products of wound skin substitutes.
  • The market contribution of wound skin substitutes anticipated to be launched in the future has been calculated based on the historical analysis of the solutions.
  • Revenues of the companies have been referenced from their annual reports for FY2022 and FY2023. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
  • The market has been mapped based on the available wound skin substitute solutions. This report has considered and profiled all the key companies with significant offerings in this field.

Primary Research:

The primary sources involve industry experts in wound skin substitutes, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and salespersons have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • Validation and triangulation of all the numbers and graphs
  • Validation of the report's segmentation and key qualitative findings
  • Understanding the competitive landscape and business model
  • Current and proposed production values of a product by market players
  • Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • Segmentations and percentage shares
  • Data for market value
  • Key industry trends of the top players of the market
  • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The competitive landscape of the wound skin substitutes market has been characterized by the presence of several key players, each offering a range of specialized products. Coloplast, for instance, has made significant strides with products such as MariGen Shield, GraftGuide Mano, and GraftGuide Micro, which are tailored to address various aspects of wound care, particularly burns and complex wounds. The companies are not only innovating in product development but also expanding their market reach and setting industry standards in the treatment of complex wounds. This dynamic competitive environment underscores the continuous evolution and technological advancement within the wound care industry.

Some prominent names established in this market are:

  • Coloplast
  • Smith & Nephew
  • MTF Biologics
  • MiMedx Group, Inc
  • AlloSource
  • Organogenesis Inc.
  • RTI Surgical
  • LifeNet Health
  • Molecular Biologicals, Inc

Table of Contents

Executive Summary

1 Market

  • 1.1 Product Definition
  • 1.2 Inclusion and Exclusion Criteria
    • 1.2.1 Inclusion
    • 1.2.2 Exclusion Criteria
  • 1.3 Key Questions Answered
  • 1.4 Analysis and Forecast Note
  • 1.5 Key Findings

2 Regions

  • 2.1 Regional Summary
  • 2.2 North America
    • 2.2.1 U.S.
    • 2.2.2 Canada
  • 2.3 Europe
    • 2.3.1 Germany
    • 2.3.2 U.K.
    • 2.3.3 France
    • 2.3.4 Italy
    • 2.3.5 Spain
    • 2.3.6 Turkey
    • 2.3.7 Netherlands
    • 2.3.8 Russian Federation
    • 2.3.9 Switzerland
    • 2.3.10 Poland
    • 2.3.11 Austria
    • 2.3.12 Czech Republic
    • 2.3.13 Sweden
    • 2.3.14 Romania
    • 2.3.15 Ireland
    • 2.3.16 Belgium
    • 2.3.17 Greece
    • 2.3.18 Portugal
    • 2.3.19 Norway
    • 2.3.20 Slovakia
    • 2.3.21 Denmark
    • 2.3.22 Ukraine
    • 2.3.23 Finland
  • 2.4 Asia-Pacific
    • 2.4.1 China
    • 2.4.2 Japan
    • 2.4.3 India
    • 2.4.4 South Korea
    • 2.4.5 Australia
    • 2.4.6 Thailand
    • 2.4.7 Malaysia
  • 2.5 Latin America
    • 2.5.1 Brazil
    • 2.5.2 Mexico
    • 2.5.3 Argentina
    • 2.5.4 Colombia
    • 2.5.5 Chile
  • 2.6 Rest-of-the-World

3 Markets - Competitive Benchmarking

  • 3.1 Key Strategies and Developments
  • 3.2 Key Companies Ecosystem

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Wound Skin Substitutes Market, $Million, 2022, 2026, and 2030
  • Figure 2: Global Wound Skin Substitutes Market (by Region), $Million, 2022, 2026, and 2030
  • Figure 3: Key Industry Trends in Global Wound Skin Substitutes Market
  • Figure 4: U.S. Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 5: Canada Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 6: Germany Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 7: U.K. Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 8: France Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 9: Italy Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 10: Spain Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 11: Turkey Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 12: Netherlands Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 13: Russian Federation Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 14: Switzerland Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 15: Poland Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 16: Austria Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 17: Czech Republic Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 18: Sweden Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 19: Romania Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 20: Ireland Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 21: Belgium Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 22: Greece Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 23: Portugal Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 24: Norway Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 25: Slovakia Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 26: Denmark Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 27: Ukraine Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 28: Finland Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 29: China Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 30: Japan Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 31: India Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 32: South Korea Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 33: Australia Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 34: Thailand Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 35: Malaysia Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 36: Brazil Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 37: Mexico Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 38: Argentina Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 39: Colombia Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 40: Chile Wound Skin Substitutes Market, $Million, 2021-2030
  • Figure 41: Data Triangulation
  • Figure 42: Top-Down and Bottom-Up Approach
  • Figure 43: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Global Wound Skin Substitutes Market, Opportunities
  • Table 3: Global Wound Skin Substitutes Market (by Region), $Million, 2021-2030
  • Table 4: North America Wound Skin Substitutes Market (by Country), $Million, 2021-2030
  • Table 5: Europe Wound Skin Substitutes Market (by Country), $Million, 2021-2030
  • Table 6: Asia-Pacific Wound Skin Substitutes Market (by Country), $Million, 2021-2030
  • Table 7: Latin America Wound Skin Substitutes Market (by Country), $Million, 2021-2030
  • Table 8: Rest-of-the-World Wound Skin Substitutes Market (by Country), $Million, 2021-2030
  • Table 9: Key Initiatives, 2021-2024
  • Table 10: Key Companies, Global Wound Skin Substitutes Market